Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 3, 2013, Pages

  Brockbank, Elly ^a   Kokka, Fani ^b   Bryant, Andrew ^c   Pomel, Christophe ^d   Reynolds, Karina ^b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d Jean Perrin Comprehensive Cancer Centre   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; CANCER STAGING; CAUSE OF DEATH; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE SEVERITY; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN SURGERY; OPERATION DURATION; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PATIENT SAFETY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; REVIEW; SURGICAL APPROACH; SURGICAL MORTALITY; SURGICAL RISK; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER; ABDOMINAL AORTA; ADULT; AGED; DISEASE FREE SURVIVAL; FEMALE; LYMPH NODE; LYMPH NODE METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); UTERINE CERVIX TUMOR;

ADULT; AGED; AORTA, ABDOMINAL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS;

MLCS; MLOWN;

EID: 84880065463     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008217.pub3     Document Type: Review

References (57)

1. Lai CH, Huang KG, Hong JH, Lee CL, Chou HH, Chang TC, et al.Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer. Gynecological Oncology 2003;89:160-7.
2. Berman ML, Lagasse LD, Watring WG, Ballon SC, Schlesinger RE, Moore JG, et al.The operative evaluation of patients with cervical carcinoma by an extraperitoneal approach. Obstetrics and Gynecology 1977;50:658-64.
3. Cosin JA, Fowler JM, Chen MD, Paley PJ, Carson LF, Twiggs LB. Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking. Cancer 1998;82:2241-8.
4. Gold MA, Tian C, Whitney CW, Rose PG, Lanciano R. Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group Study. Cancer 2008;112:1954-63.
5. LaPolla JP, Schlaerth JB, Gaddis O, Morrow CP. The influence of surgical staging on the evaluation and treatment of patients with cervical carcinoma. Gynecologic Oncology 1986;24:194-206.
6. Leblanc E, Narducci F, Frumovitz M, Lesoin A, Castelain B, Baranzelli MC, et al.Therapeutic value of pretherapeutic extraperitoneal laparoscopic staging of locally advanced cervical carcinoma. Gynecologic Oncology 2007;105:304-11.
7. Marnitz S, Köhler C, Roth C, Füller J, Hinkelbein W, Schneider A. Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer?. Gynecologic Oncology 2005;99:546-44.
8. Podczaski ES, Palombo C, Manetta A, Andrews C, Larson J, DeGeest K, et al.Assessment of pretreatment laparotomy in patients with cervical carcinoma prior to radiotherapy. Gynecologic Oncology 1989;33:71-5.
9. Ramirez P, Jhingran A, Iyer R, Euscher E, Munsell M, Soliman P, et al.Laparoscopic extraperitoneal paraaortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with PET/CT scan. SGO Abstract 46. March 2010.
10. Weiser EB, Bundy BN, Hoskins WJ, Heller PB, Whittington RR, DiSaia PJ, et al.Extraperitoneal versus transperitoneal selective paraaortic lymphadenectomy in the pretreatment surgical staging of advanced cervical carcinoma (a Gynecologic Oncology Group study). Gynecologic Oncology 1989;33:283-9.
11. Benedet JL, Bender H, Jones H 3rd, Ngan HY, Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. International Journal of Gynecology and Obstetrics 2000;70(2):209-62.
12. Benedet JL. Progress in gynecologic cancer detection and treatment. International Journal of Gynecology and Obstetrics 2000;70(1):135-47.
13. Benedetti-Panici P, Maneschi F, Cutillo G, Congiu M, Franchi M, Amoroso M, et al.Laparoscopic abdominal staging in locally advanced cervical cancer. International Journal Gynecological Cancer 1999;9:194-7.
14. Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. Journal of Clinical Epidemiology 1997;50(6):683-91.
15. Carl UM, Bahnsen J, Wiegel T. Radiation therapy of para-aortic lymph nodes in cancer of the uterine cervix. Acta Oncologica 1993;32:63-7.
16. Chatani M, Matayoshi Y, Masaki N, Narumi Y, Teshima T, Inoue T. Prophylactic irradiation of para-aortic lymph nodes in carcinoma of the uterine cervix. A prospective randomized study. Strahlentherapie und Onkologie 1995;171:655-60.
17. Choi HJ, Roh JW, Seo SS, Lee S, Kim JY, Kim SK, et al.Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study. Cancer 2006;106:914-22.
18. Chu KK, Chang SD, Chen FP, Soong YK. Laparoscopic surgical staging in cervical cancer - preliminary experience among Chinese. Gynecologic Oncology 1997;64(1):49-53.
19. CTCAE . Common terminology criteria for adverse events, v3.0 (CTCAE). ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_30 (1 February 2013).
20. Cuschieri A. Technology for minimal access surgery. Interview by Judy Jones. BMJ 1999;319(7220):1304.
21. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd Edition. London: BMJ Publication Group, 2001.
22. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-88.
23. Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, et al and the EUROCARE Working Group. EUROCARE-3: survival of cancer patients diagnosed 1990-94 - results and commentary. Annals of Oncology 2003;14 Suppl 5:v61-v118.
24. Fowler JM, Carter JR, Carlson JW, Maslonkowski R, Byers LJ, Carson LF, et al.Lymph node yield from laparoscopic lymphadenectomy in cervical cancer: a comparative study. Gynecologic Oncology 1993;51(2):187-92.
25. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5, version 2.0. IARC Press, Lyon 2004.
26. Goff BA, Muntz HG, Paley PJ, Tamimi HK, Koh WJ, Greer BE. Impact of surgical staging in women with locally advanced cervical cancer. Gynecologic Oncology 1999;74(3):436-42.
27. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490-94.
28. Haie C, George M, Pejovic MH, Chassagne D, Gerbaulet A, Horiot JC, et al.Feasibility study of an alternating schedule of radiotherapy and chemotherapy in advanced uterine cervical carcinoma. Radiotherapy and Oncology 1988;12(2):121-7.
29. Heller PB, Maletano JH, Bundy BN, Barnhill DR, Okagaki T. Clinical-pathologic study of stage IIB, III, and IVA carcinoma of the cervix: extended diagnostic evaluation for paraaortic node metastasis - a Gynecologic Oncology Group study. Gynecologic Oncology 1990;38(3):425-30.
30. Hertel H, Kohler C, Elhawary T, Michels W, Possover M, Schneider A. Laparoscopic staging compared with imaging techniques in the staging of advanced cervical cancer. Gynecologic Oncology 2002;87(1):46-51.
31. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
32. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
33. Holcomb K, Abulafia O, Matthews RP, Gabbur N, Lee YC, Buhl A. The impact of pretreatment staging laparotomy on survival in locally advanced cervical carcinoma. European Journal of Gynaecological Oncology 1999;20:90-3.
34. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al.Cancer Statistics. CA: A Cancer Journal for Clinicians 2008;58:71-96.
35. Johnson NP, Selman T, Zamora J, Khan KS. Gynaecologic surgery from uncertainty to science: evidence-based surgery is no passing fad. Human Reproduction 2008;23(4):832-9.
36. Kim SM, Choi HS, Byun JS. Overall 5-year survival rate and prognostic factors in patients with stage IB and IIA cervical cancer treated by radical hysterectomy and pelvic lymph node dissection. International Journal of Gynecological Cancer 2000;10(4):305-12.
37. Lanciano R, Calkins A, Bundy BN, Parham G, Lucci JA III, Moore DH, et al.Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study. Journal of Clinical Oncology 2005;23:8289-95.
38. Leblanc E, Gauthier H, Ouerleu D, Ferron G, Zerdoud S, Morice P, et al.Radiotherapy and Oncology. Conference: European Society for Therapeutic Radiology and Oncology, ESTRO 29 Barcelona Spain. Conference Start: 20100912 Conference End: 20100916. Conference Publication. 2010.
39. Moher D, Pham D, Jones A, Cook DJ, Jadad AR, Moher M, et al.Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352:609-13.
40. Moore DH. Surgical staging and cervical cancer. After 30 years, have we reached a conclusion?. Cancer 2008;112:1874-86.
41. Occelli B, Narducci F, Lanvin D, Querleu D, Coste E, Castelain B, et al.De novo adhesions with extraperitoneal endosurgical para-aortic lymphadenectomy versus transperitoneal laparoscopic para-aortic lymphadenectomy: a randomized experimental study. American Journal of Obstetrics and Gynecology 2000;183:529-33.
42. Parkin DM, Bray F, Ferlay JF, Pisani P. Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians 2005;55:74-108.
43. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
44. Piver MS, Barlow JJ. Para-aortic lymphadenectomy in staging patients with advanced local cervical cancer. Obstetrics and Gynecology 1974;43:544-8.
45. Querleu D. Laparoscopic paraaortic node sampling in gynecologic oncology: a preliminary experience. Gynecologic Oncology 1993;49:24-9.
46. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al.Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. New England Journal of Medicine 1999;340:1144-53.
47. Rotman M, Pajak TF, Choi K, Clery M, Marcial V, Grigsby PW, et al.Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20. JAMA 1995;274:387-93.
48. Schulz KF, Chalmers I, Hayes RJ, Altman D. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
49. Selman TJ, Mann C, Zamora J, Appleyard TL, Khan K. Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis. CMAJ 2008;178:855-62.
50. Small W Jr, Winter K, Levenback C, Iyer R, Gaffney D, Asbell S, et al.Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116. International Journal of Radiation Oncology, Biology, Physics 2007;68:1081-7.
51. Sonoda Y, Leblanc E, Querleu D, Castelain B, Papageorgiou TH, Lambaudie E, et al.Prospective evaluation of surgical staging of advanced cervical cancer via a laparoscopic extraperitoneal approach. Gynecologic Oncology 2003;91(2):326-31.
52. Subak LL, Hricak H, Powell CB, Azizi L, Stern JL. Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstetrics and Gynecology 1995;86(1):43-50.
53. Tewfik HH, Buchsbaum HJ, Latourette HB, Lifshitz SG, Tewfik FA. Para-aortic lymph node irradiation in carcinoma of the cervix after exploratory laparotomy and biopsy-proven positive aortic nodes. International Journal of Radiation Oncology, Biology, Physics 1982;8(1):13-8.
54. Tsai Cs, Lai Ch, Chang TC, Yen TC, Ng KK, Hsueh S, et al.A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic lymphadenopathy. International Journal of Radiation Oncology Biology Physics 2010;76:477-84.
55. van de Lande J, Torrenga B, Raijmakers PG, Hoekstra OS, van Baal MW, Brolmann HA, et al.Sentinel lymph node detection in early stage uterine cervix carcinoma: a systematic review. Gynecologic Oncology 2007;106(3):604-13.
56. Vergote I, Amant F, Berteloot P, Van Gramberen M. Laparoscopic lower para-aortic staging lymphadenectomy in stage IB2, II, and III cervical cancer. International Journal of Gynecological Cancer 2002;12(1):22-6.
57. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr, et al.Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. Journal of Clinical Oncology 1999;17:1339-48.